STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)
$5.08 -0.06 (-1.1673%)
Analysed STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) News Sources
Strata (SRTA) Q1 2026 Earnings Call Transcript
06-05-2026
fool.com
Strata Critical Medical, Inc. Q1 2026 Earnings Call Summary
06-05-2026
moby.co
Joby Keeps Losing Money—and the Stock Keeps Rising
06-05-2026
yahoo.com
Strata Critical Medical Announces Expiration of Warrants
07-05-2026
yahoo.com
Strata Critical Medical, Inc. Beat Analyst Profit Forecasts, And Analysts Have New Estimates
08-05-2026
yahoo.com
How The Story Is Shifting For Strata Critical Medical (SRTA) After New Analyst Assumptions
25-05-2026
yahoo.com
Strata Acquires Louisville Perfusion Services
02-06-2026
yahoo.com
Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?
16-06-2026
yahoo.com
Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery Platform
24-06-2026
yahoo.com
Strata Critical Medical Schedules Second Quarter 2026 Earnings Conference Call
21-07-2026
yahoo.com
What is the current price of STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)?
The current price of STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) is $5.08.
STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) absolute price change since previous trading day?
The absolute price change of STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) since the previous trading day is $-0.06.
STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) percentage price change since previous trading day?
The percentage price change of STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) since the previous trading day is -1.1673%.
What is the most recent average sentiment score for STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)?
The most recent average sentiment score for STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)?
The most recent sentiment for STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ) is .
SEC-8K** Filing Available For STRATA CRITICAL MEDICAL INC (SRTA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.